LGND.NASDAQLigand Pharmaceuticals INC

Form 4: Ligand CFO Executes Stock Option Exercises

Sentiment:

Statement of Changes in Beneficial Ownership

📋All filings for Ligand Pharmaceuticals INC
🔒Login to Follow

Ligand Pharmaceuticals CFO Octavio Espinoza exercised stock options for 1,736 shares of common stock on May 27, 2026.

Summary

  • CFO Octavio Espinoza exercised options to acquire 764 shares at $63.62 per share.
  • CFO Octavio Espinoza exercised options to acquire 972 shares at $52.84 per share.
  • Following these transactions, the reporting person holds 27,679 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing standard executive equity management rather than a shift in company outlook.

Positives

  • Insider demonstrates continued commitment to the company through the exercise of vested equity compensation.

Negatives

  • None noted.

Risks

  • None noted.

Future Outlook

Not applicable as this is an insider transaction report.

Industry Context

StockSavvy.ai notes that routine insider option exercises are standard corporate governance practices and generally do not signal a change in strategic direction or financial health.

Comparison to Industry Standards

  • The transaction aligns with standard executive compensation and equity vesting schedules common in the biotechnology sector.

Stakeholder Impact

  • Minimal impact on shareholders as this is a routine exercise of existing equity grants.

Key Dates

DateDescription
2026-05-27Date of earliest transaction involving stock option exercises.
2026-05-28Date of filing for the Form 4 statement.

Keywords

Ligand Pharmaceuticals, LGND, Insider Trading, Form 4, CFO, Stock Options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.